Seegene, Stock Price -1.53% at This Time... 90,093 Shares Net Bought by Individuals in Last 5 Days

As of 10:31 AM on the 25th, Seegene is trading at 251,600 KRW, down 1.53% from the previous day. The trading volume is 245,422 shares, which is about 28.11% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.

On September 23, Kim Chung-hyun, a researcher at Mirae Asset Daewoo, stated, "COVID-19 kit update. Ready to sell the All in One kit (COVID-19 + Influenza). The All in One kit, a strategic product for the second half of the year, has received European approval. Production capacity for over 30 million tests has been secured, and exports are expected to begin by the end of September. Due to COVID-19, expansion of market share in key markets such as Europe and South America is positive. However, a downside is the relatively high dependence on COVID-19 diagnostic kits compared to global diagnostic companies." He set Seegene's target price at 300,000 KRW.

Over the past five days, individual investors have net purchased 90,093 shares of Seegene, while foreigners and institutions have net sold 84,560 shares and 4,984 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.